Agomab Therapeutics NV · NASDAQ
+5,000 sh · $43.5K
+6,000 sh · $50.9K
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.